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Household arthropods are one of the most common causes of allergic diseases. Four species of cockroaches
are found to reside in Korean homes, but published work deals almost exclusively with the German and
American cockroaches. This study was undertaken to investigate the cross-reactive allergenic components of
the dusky brown cockroach, Periplaneta fuliginosa. Enzyme-linked immunosorbent assay (ELISA) inhibition
and immunoblot analyses for the dusky brown cockroach were performed with Blattella germanica and Der-
matophagoides farinae allergic sera. cDNA encoding tropomyosin, which is a well known cross-reactive pan-
allergen, was cloned by reverse transcriptase PCR, and recombinant protein was produced by using a pET-28b
expression system. Native tropomyosin was purified by ammonium sulfate fractionation and electroelution.
The immunoglobulin E (IgE) reactivities of native and recombinant tropomyosins were compared by an ELISA
inhibition study. All 30 sera tested showed P. fuliginosa-specific IgE, and the IgE-binding reactivity of the P.
fuliginosa extract was inhibited as much as 79.4% by a B. germanica extract and as much as 63.3% by a D. farinae
extract. The deduced amino acid sequence of cloned cDNA was identical with that of Periplaneta americana
tropomyosin (98.5% nucleotide sequence identity). Seven of 26 (26.9%) allergic sera had IgE specific for
recombinant protein, and the maximum inhibition of P. fuliginosa-specific IgE achieved with recombinant
tropomyosin was 37.7% at an inhibitor concentration of 10 g/ml. Native tropomyosin inhibited the binding of
IgE to the P. fuliginosa, B. germanica, and D. farinae extracts by 65.0, 51.8, and 39% at an inhibitor concen-
tration of 1 g/ml. P. fuliginosa appears to possess allergens that are highly cross-reactive with allergens of B.
germanica and D. farinae. Tropomyosin was found to be a major allergenic component accounting for the
cross-reactivity between cockroaches and dust mites.
Invertebrates which infest homes and come into close con-
tact with humans are major causative agents of allergy in sus-
ceptible individuals. The prevalence of cockroach-specific im-
munoglobulin E (IgE) antibodies has been found to be second
only to that of antibodies specific to the house dust mite and to
constitute a significant risk factor for acute asthma (27). Four
cockroach species, the German (Blattella germanica) (63 of 174
[36.2%]), the American (Periplaneta americana) (58 of 174
[33.3%]), the Japanese (Periplaneta japonica) (2 of 174
[1.1%]), and the dusky brown (Periplaneta fuliginosa) (3 of 174
[1.7%]) cockroach, have been found to infest Korean homes
(16). The dusky brown cockroach is a peridomestic pest dis-
tributed throughout much of the southeastern United States,
Japan, and southeast Asia and has become increasingly impor-
tant because this species infests shipping containers aboard
airplanes, cargo ships, and semi-truck trailers (3). However,
the literature on cockroach allergens is biased toward two
species, the German cockroach and the American cockroach,
from a total of more than 50 recorded species.
To date, six different kinds of allergens have been reported
for the German cockroach: Bla g 1, a protein of unknown
function with tandem repeats (14, 28); Bla g 2, a protein whose
primary sequence is homologous to that of aspartic proteinases
but which is without enzymatic activity (4, 29); Bla g 4, a
calcium binding protein (5); Bla g 5, a glutathione S-trans-
ferase (6); Bla g 6, troponin C (7); and Bla g 7, tropomyosin
(17). Only three allergens from the American cockroach have
been cloned: Per a 1, a protein of unknown function which is
cross-reactive with Bla g 1 (24); Per a 3, an insect storage
protein related to arylphorin (36); and Per a 7, tropomyosin
(8). No detailed studies have been performed on other cock-
roach species, which may also represent sources of indoor
allergens.
Tropomyosin is a family of closely related proteins present
in muscle and nonmuscle cells. Interestingly, tropomyosin is
also one of the best-known shellfish allergens (23). Because it
shows high cross-reactivity among shellfish and arthropods,
tropomyosin is thought to be an invertebrate pan-allergen (32).
In this study, we tried to characterize the tropomyosin from
the dusky brown cockroach and produced a recombinant tro-
pomyosin to determine the relevance of its cross-reactivity with
other well-known allergens.
MATERIALS AND METHODS
Subjects and serum samples. Human allergic serum samples were obtained
from patients attending the allergy clinic at Severance Hospital, Yonsei Univer-
sity, Seoul, Korea. The diagnosis of allergy was based on a case history and skin
prick testing. Sera from the patients were tested for the presence of IgE anti-
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bodies against Dermatophagoides farinae and B. germanica by using the Uni-CAP
system (Pharmacia, Uppsala, Sweden) (11). Sera with CAP results higher than
0.7 kU/liter were used for the study of P. fuliginosa allergy (n  30; age range, 9
to 75 years; average age, 33 years). A serum pool from 13 healthy people was
used as a negative control.
Preparation of crude extracts. Thirty grams of live or frozen cockroaches or
mites was pulverized in liquid nitrogen. The sample was defatted in 200 ml of
ethyl ether and ethyl acetate (1:1, by volume) and extracted with slow overhead
stirring at 4°C overnight in phosphate-buffered saline (PBS), pH 7.4, containing
6 mM 2-mercaptoethanol and 1/1,000 volume of protease inhibitor set III (Cal-
biochem, San Diego, Calif.). Then 1 mg of 1-phenyl-3-(2-thiazolyl)-2-thiourea
(Sigma, St. Louis, Mo.)/ml was added to prevent melanization. The extract was
then centrifuged at 10,000  g for 30 min at 4°C, and the supernatant was finally
filtered through a 0.22-m-pore-size filter (Millipore, Bedford, Mass.)
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
immunoblotting. Proteins separated on a 10% gel were electroblotted in the
XCELL II Blot module (NOVEX, San Diego, Calif.) according to the manu-
facturer’s instructions. After blotting, the nitrocellulose membrane (OSMONICS
Inc., Westborough, Mass.) was blocked with 3% skim milk in PBS containing
0.05% Tween 20, cut into 2- to 3-mm-long strips, and incubated overnight with
serum samples diluted 1/3 in PBS. The strips were subsequently incubated with
alkaline phosphate-conjugated monoclonal anti-human IgE (1:1,000 dilution in
PBS containing 0.05% Tween 20 and 1% bovine serum albumin) and visualized
by using nitroblue tetrazolium (NBT)–3-bromo-4-chloro-5-indolylphosphate
(BCIP) as a substrate (Promega, Madison, Wis.).
Molecular cloning of the cDNA encoding tropomyosin. Total RNA was iso-
lated from 100 mg of dusky brown cockroach by using TRIzol reagent (Gibco
BRL, Rockville, Md.). First-strand cDNA was synthesized from 5 g of total
RNA by using an oligo(dT) (T18) primer. Oligodeoxynucleotide primers, which
were designed for cDNA amplification of German cockroach tropomyosin (17),
were used to clone the tropomyosin of P. fuliginosa. The primer sequences used
to produce the full-length cDNA were as follows: forward primer; 5-ATGGA
TGCCATCAAGAAGAAG-3; reverse primer; 5-GTTTAGTTGCCAATAAG
TTCGG-3 Five microliters of single-stranded cDNA was mixed with the primers
in a standard PCR mixture and amplified with Taq DNA polymerase under the
following conditions. After initial denaturation at 95°C for 5 min, the samples
were subjected to 35 cycles at 94°C for 30 s, 53°C for 30 s, and 72°C for 1 min,
with a final extension at 72°C for 9 min. The PCR-amplified fragment was
isolated from a 1% agarose gel and ligated to the pGEM-T Easy vector (Pro-
mega).
Nucleotide sequence determination. Nucleotide sequences were determined
with the ABI PRISM Dye Terminator Cycle Sequencing Ready reaction kit
(Perkin-Elmer Applied Biosystems, Foster City, Calif.) and run on an ABI 373A
DNA sequencer (Perkin-Elmer Applied Biosystems) by using commercial and
sequence based primers. Sequences were analyzed by using the BLAST program.
Expression and purification of recombinant tropomyosin. The open reading
frame of tropomyosin was amplified by reverse transcriptase PCR, and the
cDNA sequence cloned into the pGEM-T Easy vector was subcloned into the
EcoRI-cut site of the pET-28b vector (Novagen, Madison, Wis.). The resultant
sequence had an additional 35 amino acids at its N terminus.
The recombinant tropomyosin was expressed in Escherichia coli BL21(DE3).
Isopropyl-1-thiogalactopyranoside (IPTG; 1 mM) was added to the bacterial
culture, which was then grown at 37°C in Luria-Bertani broth to an optical
density at 600 nm (OD600) of 0.5 in order to induce the expression of recombi-
nant protein. The culture was harvested after being induced for 4 h. The pellet
was resuspended in lysis buffer (10 mM imidazole, 300 mM NaCl, 50 mM
NaH2PO4 [pH 8.0]) and lysed by using a French press. Recombinant tropomy-
osin was purified by using nitrilotriacetic acid-agarose (QIAGEN, Valencia,
Calif.) according to the manufacturer’s protocol under native conditions.
Purification of native tropomyosin. Live cockroaches (60 g) were homoge-
nized in 200 ml of 6 mM 2-mercaptoethanol in a blender at 4°C. All subsequent
steps were performed at 4°C unless otherwise noted. The homogenate was
expressed through three layers of cheesecloth. The filtered homogenate was
mixed with 20 volumes (4 liters) of ethanol. The supernatant was allowed to
stand for 1 h and then centrifuged (centrifuge from Sorvall, Albertville, Minn.)
for 30 min at 2,000  g to collect the sediment. The supernatant was discarded,
and the sediment was resuspended in ether and then air dried. The dried residue
was extracted with gentle overhead stirring overnight in a solution containing 1
M KCl, 10 mM Tris, 6 mM 2-mercaptoethanol, 1 mg of 1-phenyl-3-(2-thiazolyl)-
2-thiourea (Sigma)/ml, 0.5 mM EDTA, and protease inhibitor set III (Calbio-
chem) (pH 7.5). The insoluble residue was removed by centrifugation at 20,000
 g for 30 min. The clear supernatant was fractionated with 40 to 55% ammo-
nium sulfate saturation. The precipitate recovered by centrifugation at 30,000 
g for 30 min was subjected to separation on a 4-to-20% polyacrylamide gradient
gel. Further purification was achieved by electroelution using a model 422 Elec-
tro-Eluter (Bio-Rad, Hercules, Calif.).
Specific IgE binding to tropomyosin. The prevalence of specific IgE antibodies
against tropomyosin was determined by an enzyme-linked immunosorbent assay
(ELISA). Briefly, each well of the microtiter plates was coated with 200 ng of
recombinant tropomyosin. Alkaline phosphatase-conjugated mouse monoclonal
anti-human IgE was then diluted 1:1,000 in PBS–0.05% Tween 20 containing 1%
bovine serum albumin (Sigma). For color development, 100 l of para-nitrophe-
nyl phosphate (1 mg/ml) (Sigma) was added and absorbance was measured by
using an automatic microplate reader (TECAN, Salzburg, Austria). Assays were
carried out in triplicate, and the mean absorbance level of the serum samples
from 13 healthy controls plus 2 standard deviations was used as the cutoff value.
ELISA inhibition test. Polystyrene microtiter plates were coated with 100 l of
a 20-g/ml P. fuliginosa, B. germanica, or D. farinae extract in 50 mM carbonate
buffer (pH 9.6) overnight at 4°C. The 1:4-diluted serum was preincubated with
various quantities of the crude extract, purified protein, or recombinant protein
for 2 h at room temperature and overnight at 4°C. After a wash, each well of the
microtiter plate was blocked with 200 l of 3% skim milk in PBS containing
0.05% Tween 20 for 1 h at room temperature. Fifty microliters of the preincu-
bated serum was then incubated for 1 h at room temperature. Specific IgE was
detected by incubation with 50 l of 1:1,000-diluted biotinylated goat anti-human
IgE (Vector, Burlingame, Calif.), followed by streptavidin-peroxidase (Sigma)
diluted 1:1,000, for 1 h and 30 min, respectively. The signal was developed by
adding 3,3,5,5-tetramethyl-benzidine (TMB; Kirkegaard & Perry Laboratories,
Gaithersburg, Md.) (32) at a concentration of 0.4 g/liter.
Nucleotide sequence accession number. The nucleotide sequence of dusky
brown cockroach tropomyosinhas been deposited at GenBank under accession
number AF454866.
RESULTS
IgE recognition profile of P. fuliginosa allergens. Thirty al-
lergic sera sensitized with both D. farinae and B. germanica
were used to examine the prevalence of IgE recognition and
the allergen profile of P. fuliginosa. All 30 allergic sera had IgE
antibodies against P. fuliginosa (Fig. 1). The molecular weight
profiles of the IgE-binding components were significantly dif-
ferent for different patients’ sera, and a number of various
proteins were recognized. All patients’ sera revealed weak or
strong IgE reactivity to high-molecular-weight components
above 70 kDa. More than one-third of the sera exhibited IgE
reactivity to 25-kDa components (serum samples 1, 2, 3, 15, 16,
19, 25, 26, 28, and 30) and to components between 36 and 49
kDa (serum samples 1, 2, 3, 11, 15, 16, 17, 19, 22, 25, 26, 28, and
30).
Cross-reactivity with B. germanica and D. farinae. An inhi-
bition ELISA was performed to investigate the cross-reactivity
of P. fuliginosa with B. germanica and D. farinae (Fig. 2). P.
fuliginosa-specific IgE binding reactivity was inhibited as much
FIG. 1. P. fuliginosa extracts were blotted onto nitrocellulose mem-
branes and probed with sera from 30 allergic patients, followed by
anti-human IgE. Positions of molecular mass markers are given on the
left. C, buffer control without serum addition; N, normal pooled sera.
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as 79.4% by B. germanica extract and as much as 63.3% by D.
farinae extract.
cDNA cloning of tropomyosin. A single fragment of approx-
imately 850 bp was produced by reverse transcriptase PCR,
cloned into the pGEM-T Easy vector, and sequenced. The
cloned sequence encoded 284 amino acids with an estimated
molecular mass of 32,739 Da and an isoelectric point of 4.59
(Fig. 3). Dusky brown cockroach tropomyosin was found to
have the same amino acid sequence as American cockroach
tropomyosin and to have 98.5% nucleotide sequence identity
with both American and German cockroach tropomyosins.
Differences between the cDNAs of P. fuliginosa tropomyosin
and P. americana tropomyosin were found at 13 positions:
positions 6 (T to C), 9 (C to G), 63 (T to C), 175 (T to C), 285
(G to A), 313 (A to C), 345 (G to A), 366 (G to A), 417 (G to
A), 480 (G to A), 633 (A to G), 658 (C to A), and 816 (C to T).
The GenBank data search program revealed that P. fuliginosa
tropomyosin shared the highest identity with the other cock-
roach tropomyosins (100% with P. americana and 98.2% with
B. germanica). It was also found to have high homology with
other allergenic tropomyosins such as those of shrimp (84 to
81%) and house dust mites (80%) (Fig. 4).
P. fuliginosa tropomyosin was designated Per f 7 in accor-
dance with the World Health Organization/International
Union of Immunological Societies (WHO/IUIS) system of al-
lergen nomenclature (20).
Expression and purification of recombinant tropomyosin.
Per f 7 cDNA was subcloned into the pET-28b expression
vector, and the molecular weight of the protein expressed was
determined by SDS-PAGE (Fig. 5a). Its estimated molecular
mass was 36.407 kDa, because it has a histidine-tag at the N
terminus, but the recombinant protein produced a band of 42
kDa. The yield of the purified protein was 6.475 mg/liter as
measured by a Bradford assay (Bio-Rad).
Purification of native tropomyosin. Native tropomyosin was
purified by ammonium sulfate fractionation and electroelu-
tion. The yield of native tropomyosin (649 g/ml) from live
cockroaches was 1.1%. The purified tropomyosin migrated as a
36-kDa band on SDS-PAGE (Fig. 5b).
IgE reactivity of recombinant tropomyosin. IgE-binding fre-
quency against recombinant Per f 7 were determined by
ELISA. The data showed that 7 of the 26 serum samples tested
(26.9%) were positive (Table 1). This result implies that other
proteins of P. fuliginosa could be more allergenic.
Inhibition of specific IgE binding to crude extracts. The
crude extract of P. fuliginosa showed a maximum inhibition of
83.1%, and recombinant tropomyosin showed 37.7% inhibi-
tion, at inhibitor concentrations of 10 g/ml (Fig. 6). Inhibition
studies were also performed with crude extracts of B. ger-
manica and D. farinae in order to investigate the cross-reactiv-
ity of tropomyosin. All three extracts (P. fuliginosa, B. ger-
manica, and D. farinae) inhibited the IgE response to various
degrees. Both the P. fuliginosa extract and native tropomyosin
inhibited the P. fuliginosa extract 65% at an inhibitor concen-
tration of 1 g/ml. Recombinant tropomyosin, however, inhib-
ited only 25.7% of the IgE response to the P. fuliginosa extract
(Fig. 6a). At the same time, the P. fuliginosa extract and native
tropomyosin inhibited the binding of IgE to the B. germanica
extract to about the same degree, 51.1 and 51.8%, respectively,
while recombinant tropomyosin inhibited this binding 23.2% at
an inhibitor concentration of 1 g/ml (Fig. 6b). Analogous
experiments were performed with the D. farinae extract. The
inhibition of IgE binding to D. farinae reached 33.7, 39.0, and
25.8% with the P. fuliginosa extract, native tropomyosin, and
recombinant tropomyosin, respectively, at an inhibitor concen-
tration of 1 g/ml (Fig. 6c).
DISCUSSION
IgE-mediated allergy is the most common cause of hyper-
sensitivity (19). Cross-reactivity by IgE is of interest because it
may reflect the pattern of clinical sensitivities (1). In this study,
FIG. 2. Inhibition ELISA of P. fuliginosa with B. germanica and D.
farinae.
FIG. 3. Nucleotide and deduced amino acid sequences of dusky
brown cockroach tropomyosin.
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we evaluated the allergenic cross-reactivities of P. fuliginosa
with D. farinae and B. germanica by inhibition ELISA. The
results suggest that these three species share allergenic
epitopes. Several lines of evidence suggest that a 36- to 40-kDa
antigen, possibly tropomyosin, could be the main cross-sensi-
tization link between disparate species (13, 26, 34). In partic-
ular, it has been reported that IgE antibodies to tropomyosin
could be induced during mite immunotherapy (35).
Only 37.7% of the P. fuliginosa crude extract was inhibited in
the present study by recombinant tropomyosin, even though it
had the same amino acid sequence as Per a 7, which is a
FIG. 4. Comparison of P. fuliginosa tropomyosin with different tropomyosins. Pf, P. fuliginosa; Pa, P. americana (accession number AF106961);
Bg, B. germanica (AF260897); Ps, Panulirus stimpsoni (AF030063); Me, Metapenaeus ensis (U08008); Ha, Homarus americanus (AF034954); Cf,
Charybdis feriatus (AF061783); Dp, D. pteronyssinus (AF016278); Df, D. farinae (D17682); Ld, Lepidoglyphus destructor (AJ250096).
FIG. 5. Purification of native and recombinant tropomyosins. Pro-
teins were separated under reducing conditions on 10% acrylamide
gels and stained with Coomassie brilliant blue. Lanes: M, molecular
size markers (in kilodaltons); L, total cell lysate of E. coli BL21 cells
bearing recombinant Per f 7 after IPTG induction; P, fraction passed
through the column; W, fraction washed from the column; E, fraction
eluted; B, bovine serum albumin; N, native tropomyosin.
TABLE 1. IgE reactivity of human sera against
recombinant tropomyosin
Serum sample Sexa Age (yr) Diagnosis Total IgE(U/ml) OD405
b
P01 M 27 Allergic asthma 1,035 0.203
P02 F 43 Allergic asthma 151 0.167
P03 F 26 Allergic rhinitis 236 0.185
P04 F 40 Allergic asthma 586 0.163
P05 M 47 Allergic urticaria 117 0.382
P06 M 28 Allergic urticaria 122 0.142
P07 F 33 Allergic asthma 426 0.153
P08 F 40 Allergic asthma 1,076 0.137
P09 M 9 Allergic asthma 1,790 0.164
P10 M 15 Atopic dermatitis 506 0.471
P11 M 36 Cough 425 0.137
P12 M 17 Allergic rhinitis 1,418 0.204
P13 M 34 Allergic urticaria 465 0.183
P14 M 75 COPDc 568 0.130
P15 M 28 Allergic asthma 1,372 0.170
P16 M 62 Allergic asthma 5,000 0.144
P17 F 20 Atopic dermatitis 5,000 0.224
P18 M 34 Allergic urticaria 1,775 0.189
P19 F 57 Allergic asthma 1,106 0.153
P20 M 21 Atopic dermatitis 3,133 0.179
P21 M 20 Allergic asthma 1,205 0.188
P22 F 31 Atopic dermatitis 1,079 0.232
P23 M 33 Atopic dermatitis 1,089 0.171
P24 F 28 Angioedema 1,774 0.412
P25 F 50 Allergic rhinitis 149 0.296
P26 M 31 Eosi nophilia 5,000 0.257
a M, male; F, female.
b The cutoff value was 0.213.
c COPD, chronic obstructive pulmonary disease.
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well-known highly cross-reactive allergen. IgE-binding fre-
quencies of recombinant tropomyosin are not consistent: 81%
in Chironomus kiiensis (18), 80.6% in D. farinae (2), 41.4% in
P. americana (8), 29% in Blomia tropicalis (37), and 5.6% in
Dermatophagoides pteronyssinus (9).
In the study using native tropomyosin, it was found that
tropomyosin is a major component accounting for cross-reac-
tivity. Even sequences that differ in one or more amino acids
were reported to still recognize and bind IgE antibodies from
shrimp allergic sera, although with somewhat different inten-
sity, in a study of tropomyosin epitopes (10). The large differ-
ences between native and recombinant tropomyosin are in
agreement with a previous report on D. farinae tropomyosin
(2).
Tropomyosin is a family of closely related proteins with
multiple functions: muscle contraction (21, 22), transport of
mRNA (12), and mechanical support of cells (15). At least 18
isoforms are known to have been generated by alternative
RNA splicing in mammalian cells (33). Moreover, a small
change in the amino acid sequence of isoforms could influence
the IgE-binding reactivity of the allergen (25). In addition,
differences between native and recombinant tropomyosin may
contribute to the different allergenicities, and fusion proteins
or the inappropriate folding of recombinant proteins may in-
fluence IgE-binding reactivity. Also, patient group differences,
such as different genetic backgrounds, may influence IgE-bind-
ing frequency.
More effort is needed to elucidate the causes of different
allergenicities, but the relevance of tropomyosin should not be
underestimated, because of its strong cross-reactivity. This
study indicates that allergenic cross-reactivity also involves al-
lergens other than tropomyosin. It is necessary that these other
allergens be examined in order to fully understand the cross-
reactivity of cockroach allergens. Studies on the relationship
between structure and allergenicity (30) in conjunction with
patient genetics could provide a basis for understanding aller-
gic disease and may allow the creation of new therapeutic
strategies (31).
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